Mobile vans deliver HIV prevention shots to unhoused angelenos
NCT ID NCT07467018
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to prevent HIV by giving a long-acting injectable medication called lenacapavir through mobile health vans. It aims to reach 100 people in Los Angeles who are unhoused or unstably housed and face barriers to regular clinic visits. Participants receive the injection every 26 weeks, and researchers track how many start and stay on the prevention regimen over a year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCLA Health Homeless Healthcare Collaborative
RECRUITINGSanta Monica, California, 90404, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a conversation prevent HIV? study tests In-Person vs. online counseling for PrEP uptake
- Could a simple app help pharmacists stop HIV?
- New counseling approach aims to boost HIV prevention in young black men who have sex with men
- New HIV vaccine strategy aims to prime and boost immune defenses
- Can a standard HIV pill rescue those who got infected on Long-Acting PrEP?
- Can mailed HIV tests help prevent spread among drug users?